TRILLIUM THERAPEUTICS INC. Active Patents
2 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2018-04-25: Application 15962540; Invention Treatment of CD47+ Disease Cells with SIRP Alpha-FC Fusions; Applicant TRILLIUM THERAPEUTICS INC.; Status Patented Case.
- 2015-06-17: Application 14653165; Invention Treatment of CD47+ Disease Cells with SIRP Alpha-FC Fusions; Applicant TRILLIUM THERAPEUTICS INC.; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2018-04-25 | 15962540 | Treatment of CD47+ Disease Cells with SIRP Alpha-FC Fusions | TRILLIUM THERAPEUTICS INC. | Patented Case | 2021-02-02 | 10906954 | US20180312563A1 | Robert Adam Uger Penka Slavtcheva Slavova-Petrova Xinli Pang | Canada Canada Canada | DENT, ALANA HARRIS |
| 2015-06-17 | 14653165 | Treatment of CD47+ Disease Cells with SIRP Alpha-FC Fusions | TRILLIUM THERAPEUTICS INC. | Patented Case | 2018-05-15 | 9969789 | US20150329616A1 | Robert Adam Uger Penka Slavtcheva Slavova-Petrova Xinli Pang | Canada Canada Canada | DENT, ALANA HARRIS |